MedPath Search

Clinical Trials

Find the latest clinical trials by condition, location & phase

Browse and search for drug information and related clinical trials

Explore a comprehensive list of organizations, including their profiles and details.

Latest updates on clinical trials, pharmaceuticals, and healthcare companies

DeepMed Research

|

Filters

Study Phase

Early Phase 1

Phase 1

Phase 1/2

Phase 2

Phase 2/3

Phase 3

Phase 4

Not Applicable

Recruitment Status

Recruiting

Not yet recruiting

Active, not recruiting

Completed

Suspended

Terminated

Withdrawn

Study Type

Interventional

Observational

Expanded Access

Others

Eligibility Sex

All

Female

Male

Healthy Volunteers

All

Include

Exclude

Found 539635 clinical trials

Sort by:

Patients' Experiences of Information After Total Knee Arthroplasty - A Qualitative Interview Study

Not yet recruiting

Conditions: Knee Osteoarthrosis
Total Knee Arthroplasty

First Posted Date: 2025-05-29

Last Posted Date: 2025-05-29

Lead Sponsor: Vastra Gotaland Region

Target Recruit Count: 15

Registration Number: NCT06994884

Optimizing Pain Treatment in Children On Mechanical Ventilation

Phase 3

Not yet recruiting

Conditions: Mechanical Ventilation
Pediatric Acute Respiratory Failure
Analgesics, Opioid
Sedation and Analgesia

Interventions: Drug: Acetaminophen
Drug: Ketorolac
Drug: Placebo

First Posted Date: 2025-05-29

Last Posted Date: 2025-05-29

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 644

Registration Number: NCT06994442

Locations: 🇺🇸
Arkansas Children's Hospital, Little Rock, Arkansas, United States
🇺🇸
Children's National Hospital, Washington, District of Columbia, United States
🇺🇸
Primary Children's Medical Center, Salt Lake City, Utah, United States

and more 12 locations

Phase I Study of HBT-708 for Patients With Advanced Solid Tumors

Phase 1

Not yet recruiting

Conditions: Advanced Solid Tumors

Interventions: Drug: HBT-708

First Posted Date: 2025-05-29

Last Posted Date: 2025-05-29

Lead Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.

Target Recruit Count: 60

Registration Number: NCT06993870

Discontinuation of Tobacco Dependence in Smoking Patients With Squamous Cell Carcinoma of the Head-neck District: Multicenter Prospective Observational Study

Not yet recruiting

Conditions: Cancer of Head and Neck

First Posted Date: 2025-05-29

Last Posted Date: 2025-05-29

Lead Sponsor: Azienda Ospedaliero-Universitaria Careggi

Target Recruit Count: 200

Registration Number: NCT06995417

Locations: 🇮🇹
Azienda Ospedaliera Careggi, Florence, Firenze, Italy

An Open-label Study in Healthy Adults to Evaluate the Relative Bioequivalence of a Single-dose Administration of Sonelokimab Either by a Prefilled Syringe or an Autoinjector

Phase 1

Not yet recruiting

Conditions: Relative Bioequivalence

Interventions: Drug: Sonelokimab

First Posted Date: 2025-05-29

Last Posted Date: 2025-05-29

Lead Sponsor: MoonLake Immunotherapeutics AG

Target Recruit Count: 120

Registration Number: NCT06994936

The Application of "HUAXI Hole 1" in Reverse-sequence Endoscopic Nipple-sparing Mastectomy With Direct-to-implant Breast Reconstruction

Not Applicable

Not yet recruiting

Conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3)

First Posted Date: 2025-05-29

Last Posted Date: 2025-05-29

Lead Sponsor: Du Zhenggui

Target Recruit Count: 337

Registration Number: NCT06995118

Locations: 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China
🇨🇳
Guangzhou First People's Hospital, Guangzhou, Guangdong, China
🇨🇳
Anyang City Tumor Hospital, Anyang, Henan, China

and more 16 locations

Caregiver Stress, Mental Health, and Self-Efficacy in ADHD Households

Completed

Conditions: ADHD

First Posted Date: 2025-05-29

Last Posted Date: 2025-05-29

Lead Sponsor: Alexandria University

Target Recruit Count: 160

Registration Number: NCT06994000

Locations: 🇸🇦
Qassim University, Al Qassim, Qassim, Saudi Arabia

Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)

Phase 2

Not yet recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Talquetamab
Drug: Teclistamab

First Posted Date: 2025-05-29

Last Posted Date: 2025-05-29

Lead Sponsor: Noffar Bar

Target Recruit Count: 50

Registration Number: NCT06993675

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Minimally Invasive Posterior Decompression of the Cervical Spine

Not Applicable

Not yet recruiting

Conditions: Cervical Degenerative Disc Disease
Cervical Stenosis
Posterior Spine Surgery

First Posted Date: 2025-05-29

Last Posted Date: 2025-05-29

Lead Sponsor: N.N. Priorov National Medical Research Center of Traumatology and Orthopedics

Target Recruit Count: 30

Registration Number: NCT06995300

Locations: 🇷🇺
Priorov National Medical Research Center of Traumatology and Orthopedics, Moscow, Russian Federation

CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Non-contrast CT Based EXtended Window Thrombolysis

Phase 3

Not yet recruiting

Conditions: Acute Ischemic Stroke

Interventions: Drug: 0.25mg/kg TNK
Drug: Standard medical treatment

First Posted Date: 2025-05-29

Last Posted Date: 2025-05-29

Lead Sponsor: Huashan Hospital

Target Recruit Count: 890

Registration Number: NCT06994975

Locations: 🇨🇳
Huashan Hospital, Fudan University, Shanghai, China

Prev
1
22
23
24
25
26
100
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy